ARCHIVES

Zofran Label Change Includes Warnings of QT Prolongation

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Scientific Process

September 25, 1998

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981

Senate Emphasizes Balance In NCI’s Research Programs

September 24, 1993

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010